Christopher Chen, MD, PhD is the William F. Warren Distinguished Professor of Biomedical Engineering at Boston University. His research focuses on mechanobiology, tissue engineering, and biomaterials, with a particular emphasis on vascular, cardiac, and stem cell systems. He directs the Chen Lab - Tissue Microfabrication Lab, pioneering technologies like ESCAPE for precise tissue engineering. Additional roles include Founding Director of the Biological Design Center and Deputy Director at the NSF Engineering Research Center for Cellular Metamaterials. Education: A.B. in Biochemistry (Harvard College), M.S. in Mechanical Engineering (MIT), PhD in Medical Engineering (Harvard-MIT HST), and MD (Harvard Medical School). Research interests span mechanobiology across scales, 3D organotypic culture platforms, and regenerative medicine. His lab develops microfluidic systems, biomimetic tissues, and tools for studying cell-matrix interactions. Notable achievements include the Shu Chien Achievement Award and contributions to vascularization strategies for engineered tissues. Awards: Shu Chien Achievement Award, featured in NIH Director's Blog and Wyss Institute news. Labs/Teams: Chen Lab - Tissue Microfabrication Lab, Biological Design Center, and leadership in the NSF-funded Mechanobiology and Cellular Metamaterials centers.
Ruogang Zhao is a Professor in the Department of Biomedical Engineering at the University at Buffalo, affiliated with the School of Engineering and Applied Sciences. His research focuses on cytoskeleton mechanics, cell motility, and the molecular basis of pulmonary diseases. He leads studies on engineered tissue models (e.g., lung microtissues) to investigate fibrosis mechanisms and develop anti-fibrosis therapies. Dr. Zhao’s work integrates 3D bioprinting, organ-on-a-chip systems, and mechanobiology to address challenges in regenerative medicine and disease modeling. Key research areas include: Development of biomimetic microtissue platforms for drug screening Role of mechanical forces in macrophage activation and fibrosis progression 3D printing of hydrogels with tunable mechanical properties for biomedical applications Effects of e-cigarette components on lung fibroblast behavior and repair processes His recent work emphasizes translational research, such as force-sensing microfabricated devices and lung-targeted nanotherapeutics. Dr. Zhao’s contributions span biomaterials science, immunology, and mechanobiology, with applications in respiratory disease and cancer therapy. He directs the Cell, Gene and Tissue Engineering Center at the University at Buffalo, fostering interdisciplinary collaboration in bioengineering.
Yu Huang is an Associate Professor in the Department of Biological Engineering at Utah State University's College of Engineering, where he leads the MicroBrain Laboratory. His research focuses on BioMEMS and microtissue engineering of neurons, tumors, and stem cells with applications in neuroscience, regenerative medicine, and cellular therapy. Dr. Huang earned his educational credentials from prestigious institutions: PhD in Materials Science, University of Wisconsin-Madison, 2011 MS in Materials Science, University of Wisconsin-Madison, 2010 BS in Chemistry, Beijing University, 2001 Dr. Huang's research interests center on BioMEMS (microfabrication technology for biomedical applications), biomaterials, microfluidics, and tissue engineering. His laboratory specializes in microtissue engineering of neurons, tumors, and stem cells, with applications spanning neuroscience, neuro-engineering, regenerative medicine, cell assay development, and cellular therapy. His work bridges engineering principles with biological systems to create innovative solutions for healthcare challenges. His publication record demonstrates consistent focus on neural tissue engineering, organoid development, and microfabrication technologies. Recent work emphasizes brain organoid modeling, 3D-printed biomaterials, and microfluidic platforms for neural and cancer research. His publications appear in high-impact journals including Nature Biotechnology, ACS Nano, and NanoScale, reflecting the interdisciplinary nature of his work at the intersection of engineering and biology. Dr. Huang has received numerous prestigious awards recognizing his research and teaching excellence: NSF CAREER Award (2022) NIH MIRA Award (2021) Multiple Faculty Research Excellence Awards from USU (2022-2023) Outstanding Graduate and Undergraduate Mentor Awards Young Investigator Award from Society for Biomaterials (2022) As an educator and mentor, Dr. Huang has guided numerous graduate and undergraduate students through research projects in his MicroBrain Lab. His teaching portfolio includes BioMEMS, Engineering Properties of Biological Materials, and Graduate Seminar courses. His lab actively recruits students interested in neural engineering, cancer research, and biomaterials development, providing hands-on research experience in state-of-the-art facilities. The MicroBrain Laboratory maintains active collaborations across disciplines, focusing on engineering micro-environments for neural tissue development, cancer migration studies, and therapeutic applications of engineered tissues. Current projects include organoid engineering, anti-inflammatory compound studies, and development of novel biomaterials for neural applications.
Matthew Walker serves as a PartTime Lecturer at the UWA Law School, The University of Western Australia, with research output paradoxically centered in bioengineering and biomechanics rather than legal studies. His work bridges mechanical engineering principles with cellular biology. His core research investigates: Mechanical force transduction in biological tissues Myofibroblast activation pathways in fibrotic diseases Stress relaxation dynamics in 3D microtissue models TGF-β1-mediated cellular responses to mechanical strain Analysis of his 2020 publications reveals a concentrated focus on quantifying mechanical properties of engineered tissues, particularly time-dependent viscoelastic behavior and mechanotransduction mechanisms. This work establishes foundational methodologies for modeling tissue repair processes with direct implications for fibrosis treatment and regenerative medicine.
Heidi Declercq is an Associate Professor at the Faculty of Medicine , KU Leuven , affiliated with the Department of Development and Regeneration . Her research focuses on advanced tissue engineering and bioprinting techniques to create functional, vascularized biological constructs. Current projects: Automated bioprinted liver constructs (2025-2028), innovative tooth bioprinting strategies (2024-2028), and vascularized myogenic tissue development (2023-2027). Research emphasizes smart biomaterials , spheroid-based microtissues , and hybrid nanocomposites for regenerative applications. Her work spans translational research in biomedical engineering , with publications analyzing vascularization mechanisms, bioprinting methodologies, and cell death assays in 3D cultures. She contributes to teaching courses on biomaterials and tissue engineering principles, and participates in institutional academic governance as a senior academic staff member.
Prof. Dr. Timo Betz is a Professor of Biophysics at the Third Institute of Physics, Georg August University Göttingen, leading the Betz-Lab located at Friedrich-Hund-Platz 1, Room F.03.123, 37077 Göttingen, Germany. His research focuses on deciphering the fundamental physical processes that confer stability and robustness to living systems despite their complexity, non-equilibrium nature, and non-linear dynamics. The Betz-Lab investigates how mechanics influences biological function across multiple scales, from intracellular processes to tissue-level phenomena. Their work spans cell mechanics, tissue mechanics, and the development of novel biophysical measurement techniques. A central theme is understanding the intricate dependencies between biochemical signaling, mechanical forces, and viscoelastic properties in living systems. The lab develops advanced instrumentation including optical tweezers-based microrheology systems and custom microscopy approaches to quantify forces and tension in 3D biological environments. Analysis of Dr. Betz's recent publications (2023-2025) reveals a strong emphasis on intracellular mechanics, particularly through the development of the 'Mean Back Relaxation' (MBR) method for characterizing active processes from spontaneous fluctuations. His research spans diverse biological systems including zebrafish embryogenesis, cancer cell migration, and skeletal muscle mechanics, consistently bridging fundamental physics with biological applications. Notable methodological contributions include BeadBuddy software for analyzing elastic stress sensors and advanced traction force microscopy techniques for nonlinear materials. Dr. Betz leads a vibrant research team comprising multiple PhD students, postdoctoral researchers, and technical staff. His laboratory has developed significant software tools including BeadBuddy for analyzing fluorescent force sensors in biological tissue and collagen deformation analysis tools. The lab receives funding from multiple sources as indicated by their acknowledgments of support. The Betz-Lab maintains several active research projects: Intracellular passive and active microrheology to study organelle distribution and intracellular forces Collective cell migration in development, using zebrafish epiboly as an in vivo model Collective cancer cell migration in structured 3D environments Investigating mechanical niche cues in skeletal muscle stem cell activation Developing specialized tissue chambers for high-resolution imaging of living muscle and connective tissue Designing new instrumentation and analysis software for biophysical measurements
Dr. Deepali Pal is a researcher at Newcastle University, where she leads cutting-edge studies in leukemia biology and stem cell research. Her work focuses on understanding the bone marrow microenvironment's role in treatment resistance and developing innovative 3D models for cancer drug testing. Research Interests: Dr. Pal's investigations span multiple disciplines including: Leukemia microenvironment interactions Stem cell-derived cancer models Epigenetic drivers of treatment resistance Non-animal testing platforms for drug development Therapeutic targeting of redox systems Chromosomal instability mechanisms in blood cancers Her recent publications demonstrate a strong emphasis on translational oncology, with frequent use of patient-derived models, organoid engineering, and molecular profiling to identify clinically actionable targets. The work consistently bridges basic cancer biology with therapeutic innovation.
Jeffrey R Morgan is a tenured Professor at Brown University , holding dual appointments in the School of Engineering and Department of Pathology and Laboratory Medicine . He directs the Center for Alternatives to Animals in Testing and has pioneered the 3D PetriDish® technology for scaffold-free tissue engineering. Education : PhD (Harvard), BS (Syracuse) Key Collaborators : Kim Boekelheide, Eric Darling, Anubhav Tripathi Research Focus : 3D Tissue Engineering – Developing complex microtissue geometries (toroids, honeycombs) and studying tissue fusion for organ-scale fabrication. Cell-Cell Mechanics – Quantifying forces in multicellular aggregates to understand fibrosis and tissue remodeling. Drug Transport – Using spheroids to model drug uptake, efflux pumps, and multi-drug resistance in cancer. Article Trends : Recent work emphasizes 3D spheroid platforms for toxicity testing , collagen mechanics , and automated bio-manufacturing tools . Keywords span Biomedical Engineering , Tissue Morphogenesis , and Drug Discovery , with sub-fields including ECM alignment , microtissue hydrodynamics , and scaffold-free organoids . Scientific Recognition : 1996 La Roche-Posay Prize 2015 National Academy of Inventors Fellow 2016 American Institute of Medical and Biological Engineering Fellow 2014-2025 Editorial roles and collaborative grants Labs and Teams : Leads a multidisciplinary lab at Brown collaborating with engineers, pathologists, and biomedical researchers. His team focuses on self-assembling microtissues , drug transport quantification , and toxicity modeling , with partnerships in the Center for Alternatives to Animals in Testing and School of Engineering .
Prof. Kristian Franze is the Director of the Institute of Medical Physics and Microtissue Engineering at Friedrich-Alexander University Erlangen-Nürnberg (FAU) and the Max Planck Center for Physics and Medicine (MPZPM) since August 2020. His interdisciplinary research combines physics and medical science to investigate the interaction between mechanical forces and nervous system biology. Education: Veterinary Medicine, University of Leipzig Doctorate in Physics, University of Leipzig His groundbreaking work in neural mechanics focuses on the role of mechanical cues in nerve development, function, and regeneration. By integrating medical physics, microtissue engineering, and mechanobiology, Franze's research advances understanding of neurological disorders and informs tissue engineering strategies. His work has positioned him as a leader in interdisciplinary neuroscience research. Scientific Awards: Alexander von Humboldt Professorship (Germany's most highly endowed research prize) Feodor Lynen Research Fellowship from the Humboldt Foundation Labs and Teams: Institute of Medical Physics and Microtissue Engineering at FAU Max Planck Center for Physics and Medicine (MPZPM), a joint initiative of the Max Planck Institute for the Physics of Light (MPL), FAU, and University Hospital Erlangen
Andrea Garmyn is an Academic Specialist in Teaching and Outreach at Michigan State University's Department of Food Science and Human Nutrition, within the College of Agriculture & Natural Resources. She serves as faculty coordinator and coach for the MSU Meat Judging Team, faculty liaison for the MSU Meat Laboratory, and teaches courses such as ANS 200B (Introduction to Meat Evaluation), ANS 300B (Advanced Meat Judging), and FSC 433 (Food Processing - Muscle Foods). Ph.D., Oklahoma State University (2009) M.S., Kansas State University (2007) B.S., The Ohio State University (2004) Research Focus: Her work centers on improving beef and lamb eating quality through production and post-mortem processing strategies. She investigates consumer sensory outcomes, carcass grading systems, enhancement techniques, and the impact of finishing diets on meat characteristics. Recent projects have explored smoked brisket quality, cross-cultural consumer preferences, and sustainable livestock systems. Recent Publication Trends: Analysis of USDA and MSA grading systems, international consumer acceptance studies, sustainable feedlot practices, and technological interventions in meat processing. Her work spans both applied research (e.g., Honduras-U.S. beef comparisons) and theoretical studies (e.g., myogenic/adipogenic tissue engineering). Professional Affiliations: Active member of the American Meat Science Association , American Association of Meat Processors , Michigan Meat Association , and American Society of Animal Science . She contributes to MSU Extension programs and industry outreach initiatives. Labs & Facilities: Oversees the MSU Meat Laboratory, which engages in teaching, research, and meat sales. The Meat Lab serves as a hub for hands-on learning in meat processing and evaluation.
Aslak Tveito is a Professor and Simula Fellow at Simula Research Laboratory, working within the Department of Computational Physiology. His research spans computational physiology, biophysics, and scientific computing with a strong focus on cardiac electrophysiology and mathematical modeling. Dr. Tveito's research interests center on computational physiology, particularly in the domain of cardiac electrophysiology. His work integrates mathematical modeling, numerical analysis, and computational techniques to understand cardiac function at multiple scales - from cellular to tissue level. He has made significant contributions to developing computational frameworks for modeling excitable tissues, with particular emphasis on the heart. His research bridges the gap between theoretical mathematics and practical physiological applications, creating models that can predict cardiac behavior under normal and pathological conditions. The publication record reveals a strong trend toward increasingly detailed cellular-level modeling of cardiac electrophysiology. Recent work focuses on nano-scale phenomena, stem cell-derived cardiomyocyte modeling, and the development of efficient computational frameworks that maintain physiological accuracy. His research demonstrates a consistent trajectory from macroscopic cardiac models toward cellular and subcellular resolution, with growing integration of experimental data from microphysiological systems. There's also a clear emphasis on practical applications, particularly in drug testing and arrhythmia mechanisms. Dr. Tveito has established himself as a leading researcher in computational cardiac electrophysiology through his extensive publication record spanning multiple decades. His work has been published in high-impact journals across computational biology, physiology, and applied mathematics. His research program demonstrates strong continuity in mathematical modeling of cardiac systems, with evolving focus toward higher-resolution cellular models and integration with experimental cardiac microphysiological systems. The collaborative nature of his work is evident through numerous co-authorships with both computational scientists and experimental biologists.
Samuel Wall serves as Chief Research Scientist and Research Professor in the Department of Computational Physiology at Simula Research Laboratory. His work focuses on developing computational models to understand cardiac electromechanics, with particular emphasis on stem cell-derived cardiomyocytes and personalized heart modeling approaches. His research interests span computational cardiac physiology, mechano-electric feedback mechanisms, stem cell-derived cardiomyocyte modeling, and drug response prediction. Wall's work integrates advanced computational methods with experimental cardiac physiology to create in-silico tools for evaluating cardiac function, tissue engineering applications, and drug effects. His research has significant implications for understanding arrhythmia mechanisms, cardiac remodeling, and developing more accurate preclinical drug testing platforms. Analysis of Wall's recent publications reveals a strong trend toward integrating computational modeling with microphysiological systems, particularly using human-induced pluripotent stem cell-derived cardiomyocytes. His work increasingly focuses on creating in-silico augmented platforms that combine experimental measurements with computational analysis to improve drug response prediction and understand fundamental cardiac mechanisms. The research spans multiple scales from sub-cellular mechanics to whole-organ function. Wall maintains active collaborations with leading institutions in cardiac modeling and biomedical engineering. His work frequently appears in high-impact journals spanning computational science, physiology, and biomedical engineering fields.
Dr. Brian P. Johnson is an Assistant Professor at Michigan State University, jointly appointed in the Department of Pharmacology & Toxicology and the Department of Biomedical Engineering. His interdisciplinary research focuses on designing biomimetic microenvironments to study intercellular signaling in development and disease, particularly using 3D printing and CNC machining for high-throughput cancer models and endocrine disruption studies. Ph.D. in Molecular and Environmental Toxicology, University of Wisconsin Postdoctoral training in Biomedical Engineering, University of Wisconsin His work addresses: Chemical mixtures disrupting epithelial-mesenchymal signaling in orofacial development Mechanisms of cancer treatment resistance via multicellular models Computational modeling of thyroid homeostasis perturbations Translational strategies for precision disease treatment Articles highlight trends in microtissue engineering, computational endocrinology, and cancer-immune microenvironment interactions.
